AbbVie CEO Robert Michael will be paid $32.5 million in 2025, his second year on the job, a significant 75%…

Serious diseases that affect the transparent part of the eye called the cornea are very difficult to treat because this…

A new biotechnology company created through an Australian-Danish partnership will accelerate treatments for children and adults with heart disease. The…

A new study led by researchers at VIB and the University of Leuven shows that immune cells called microglia may…

As the population ages, the need for better tools to diagnose and monitor Alzheimer’s disease (AD), the most common cause…